(Aryloxy)alkylamines as Selective Human Dopamine D4 Receptor Antagonists: Potential Antipsychotic Agents

MLA

David T. Connor, et al. “(Aryloxy)Alkylamines as Selective Human Dopamine D4 Receptor Antagonists: Potential Antipsychotic Agents.” Journal of Medicinal Chemistry, vol. 40, Dec. 1997, pp. 4026–29. EBSCOhost, https://doi.org/10.1021/jm970422s.

APA

David T. Connor, Robert Doubleday, Lawrence D. Wise, Robert G. MacKenzie, Thomas Capiris, Thomas G. Heffner, Steven Robert Miller, Thomas A. Pugsley, & Paul C. Unangst. (1997). (Aryloxy)alkylamines as Selective Human Dopamine D4 Receptor Antagonists: Potential Antipsychotic Agents. Journal of Medicinal Chemistry, 40, 4026–4029. https://doi.org/10.1021/jm970422s

Chicago

David T. Connor, Robert Doubleday, Lawrence D. Wise, Robert G. MacKenzie, Thomas Capiris, Thomas G. Heffner, Steven Robert Miller, Thomas A. Pugsley, and Paul C. Unangst. 1997. “(Aryloxy)Alkylamines as Selective Human Dopamine D4 Receptor Antagonists: Potential Antipsychotic Agents.” Journal of Medicinal Chemistry 40 (December): 4026–29. doi:10.1021/jm970422s.